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INTRODUCTION
Small GTPases of the Rho subfamily work as regulatory switches
and play essential roles in Actin cytoskeleton organisation, cell:cell
adhesion, cell:substrate adhesion, cell polarity, cytokinesis, cell
cycle progression and cell migration. The Rho subfamily of genes is
highly conserved in evolution and comprises three major members,
Rho, Rac and Cdc42, which cycle between an active GTP-bound
and an inactive GDP-bound state (Jaffe and Hall, 2005; Symons and
Settleman, 2000). The GTPase switch GTP/GDP is determined by
the action of two main classes of regulatory proteins: the Guanine
nucleotide exchange factors (GEFs), which act as GTPase activators
by releasing GDP and allowing its replacement by GTP (Rossman
et al., 2005), and the GTPase activating proteins (GAPs), which
promote the GTPase inactive state by stimulating its GTP
hydrolysing capacity (Moon and Zheng, 2003).
Spatial and temporal restriction of small RhoGTPase activity
inside a cell is fundamental, for example, to the regulation of
movements and cell-cell contacts that are required for
morphogenesis. During the formation of epithelia, Rac and Cdc42
are specifically recruited to the cadherin-cadherin contact sites
formed between neighbouring cells, where they drive the
formation of filopodia and/or lamellipodia that will contribute to
generate intimate cell-cell contacts (Braga, 2000). Another
example of spatially restricted RhoGTPase activity has been found
during migration of single cells, in which Rac-GTP accumulates
at higher levels at the leading edge (Kraynov et al., 2000), where
it induces Actin polymerisation and integrin adhesion complex
assembly.
Evidence that the spatial and temporal control of small
RhoGTPase function must be correlated with the activity of Rho
regulators during tissue morphogenesis is suggested from studies on
cell shape changes occurring during gastrulation and neurulation. In
Drosophila gastrulation, a secreted factor Folded gastrulation (Costa
et al., 1994) initiates a signal through interaction with a G protein-
coupled receptor (still unknown) and a heterotrimeric G protein 
subunit, Concertina (Parks and Wieschaus, 1991) to activate
DRhoGEF2, the small GTPase Rho1 and subsequently Myosin II
(Barrett et al., 1997; Nikolaidou and Barrett, 2004). This pathway is
essential to induce constriction of the apical surface of mesodermal
cells, leading to their invagination. In vertebrates, apical constriction
of neuroepithelial cells, mediated by reorganisation of the Actin
cytoskeleton, contributes to closure of the anterior neural tube.
Interestingly, mice mutant for p190 RhoGAP show defects in
anterior neural tube closure, due to failure in apical constriction and
in intracellular re-organisation of the Actin cytoskeleton of
neuroepithelial cells (Brouns et al., 2000). Together, these
observations suggest that Rho acts apically during constriction of
(neuro)epithelial cells and its function is tightly regulated by
RhoGEF and RhoGAP activities.
Despite this, it is still unclear how spatially localised activation of
small RhoGTPases is achieved and, with few exceptions (Bement et
al., 2005), no tools exist that allow the direct visualisation of their
activity during embryonic development. Additionally, little is known
about how Rho regulators spatially and temporally control their
targets in vivo, during the complex morphogenetic movements that
shape the embryo.
Cell invagination is a widespread movement during
embryogenesis and it is commonly dependent on Rho function (Pilot
and Lecuit, 2005). Using the posterior spiracles of the Drosophila
embryo as a model, we show that apically localised Myosin II and
Rho1 are essential to control this morphogenetic movement. By
expressing a GFP-based probe that allows the visualisation of active
Rho1, we present evidence that during cell invagination this
RhoGTPase is exclusively activated on the apical membrane of
epithelial cells. Correlating with this local activation, we found that
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two Rho1 activators (RhoGEF2 and RhoGEF64C) are upregulated
and localise apically in the invaginating cells, while a Rho1 inhibitor,
the RhoGAP Cv-c (Crossveinless-c), occupies the complementary
basolateral membrane domain. This differential distribution of Rho
regulators is required for the correct function of Rho1, which drives
invagination of epithelial cells.
MATERIALS AND METHODS
Fly strains and genetics
The following fly strains were used: yw; ubi-DE-Cad-GFP (Oda and
Tsukita, 2001); SqhAX3; ubi-Sqh-GFP (Royou et al., 2002); ems-GAL4
(Merabet et al., 2002); UAS-Cat-GFP (Oda and Tsukita, 1999); UAS-
GFP-Actin (Verkhusha et al., 1999); UAS-mRFP-Actin#30 (this study);
UAS-GFP (Bloomington Stock Center); UAS-RhoN19 (Strutt et al.,
1997); UAS-PNKG58AeGFP (this study); UAS-RhoV14 (Fanto et
al., 2000); UAS-RacN17 (Luo et al., 1994); UAS-DRhoGEF64C FL
and UAS-DRhoGEF64CDbl (Bashaw et al., 2001); UAS-
GEF64C53UTR (this study); UAS-Cv-c (Denholm et al., 2005); UAS-
Venus-Cv-c-93 (this study); rho11B/CyO (Magie and Parkhurst, 2005);
rho172R/CyO (Strutt et al., 1997); RpII140wimp/TM3 Sb1 (Bloomington
Stock Center); gef64C1/TM3 and gef64C29/TM3 (Bashaw et al., 2001);
P[FRT(whs)]G13 DRhoGEF2I(2)04291/CyO (Hacker and Perrimon, 1998);
yw P[FRT(whs)]101 sqh1/FM7 (Karess et al., 1991); cv-c7/TM3 (Denholm
et al., 2005).
Germline clones of DRhoGEF2I(2)04291 and sqh1 were generated using the
FLP-DFS system (Chou and Perrimon, 1996). yw P[FRT(whs)]101 sqh1/w*
P[FRT(whs)]101 ovoD1 females carrying germline clones were crossed with
w; ems-GAL4 UAS-GFP-Actin males. Maternal and zygotic mutants for
rho11B were generated using the wimp strategy (Magie et al., 1999).
Live imaging
Embryos expressing ubi-DE-CadGFP or GFP-Actin with the ems-GAL4
driver were prepared for live imaging and analysed as described (Woolner
et al., 2005).
Molecular biology and transgenic lines
To express PKNG58AeGFP, we generated pUAST-PKNG58AeGFP. The N-
terminus of Drosophila PKN (first 339 amino acids), including the point
mutation G58A, was PCR amplified from pCasperPKNG58A (kind gift
from Jeffrey Settleman). This PCR fragment was cloned into the EcoRI/XbaI
sites of pUAST (Brand and Perrimon, 1993). Next, eGFP was PCR
amplified from pEGFP-N1 (Clontech) and cloned into the XbaI site of the
previous construct.
Venus-Cv-c was generated by cloning the full-length cDNA of cv-c
(Denholm et al., 2005) into the pENTR directional TOPO cloning vector
(pENTR/D) and subsequently transferred into pTVW (UASt promoter, N-
terminal Venus tag – obtained from DGRC) using the Gateway technology
(Invitrogen).
mRFP-Actin was made by fusing the 700 bp fragment of mRFP
(Campbell et al., 2002) with 1100 bp of Drosophila Actin 5c, and cloned into
pUAST.
pUAST-RhoGEF64C53UTR was obtained by digestion of
pUASTGEF64C FL (Bashaw et al., 2001) with EcoRI and NheI and
subcloning the resulting fragment into pUAST. Transgenic flies were
generated using standard procedures.
S2 cell culture, RNAi and transfection
Drosophila Schneider S2 cells were cultured and RNAi was performed
according to Clemens et al. and Schneider (Clemens et al., 2000; Schneider,
1972). Templates for in vitro transcription of Rho1 were generated as
described below for RhoGEF64C, and contained 527 bp from position 655
(CG8416-RC). Expression of PKNG58AeGFP in S2 cells was obtained by
co-transfection of 20 ng of pUAST-PKNG58AeGFP with 100 ng of
pAc5.1/V5-HisB-GAL4 in six well plates. In some cases, 100 ng of the
active forms RhoV14, RacV12, Cdc42V12 or for the dominant-negative,
RhoN19, RacN17 or Cdc42N17 cloned in pUAST were also co-transfected
by using the CellFectin method according to the manufacturer’s
specifications (Invitrogen Life Technologies).
GTPase-binding assays
S2 cell extracts expressing PKNG58AeGFP were prepared 24 hours post-
transfection, in lysis buffer [50 mmol/l Tris (pH 7.8), 150 mmol/l NaCl, 1%
Nonidet-40], and were precleared twice with protein A-Sepharose beads for
30 minutes (4°C). Drosophila Rho1, Rac1, Rac2 and Cdc42-GST proteins
were prepared according to standard methods and pre-incubated with GDP
or GTPS according to (Lu and Settleman, 1999). GTPase binding to
PKNG58AeGFP was next assayed by SDS-PAGE, followed by
immunoblotting with an anti-GFP monoclonal antibody (Roche).
RNA interference in embryos
For the synthesis of dsRNA for RhoGEF64C, a region of 773 bp from
position 1237 (CG32239-RA) was PCR amplified from genomic DNA with
primer pairs containing the T7 promoter sequence at the 5 end. The PCR
products were used as templates for the T7 transcription reactions with the
T7 Ribomax Large Scale Production Kit (Promega). The dsRNA was
dissolved in injection buffer at a final concentration of 2.2 g/l and injected
into 0- to 1-hour-old embryos derived from the cross between w; ems-GAL4
UAS-GFP-Actin females and yw males.
In situ hybridisation, immunohistochemistry and cuticle
preparations
Whole-mount in situ hybridisation was carried out using standard methods
(Lehmann and Tautz, 1994) with a digoxigenin-labelled probe generated by
transcription of DRhoGEF64C (CG32239-RA) DNA region 1237-2010
(nucleotide positions).
For immunohistochemistry, embryos were dechorionated in commercial
bleach, fixed in a 1:1 mix of formaldehyde 4% in PBS (Ca2+ free): n-heptane
for 30 minutes at room temperature and hand devitellinised. The following
primary antibodies were used: mouse anti-Armadillo (N2 7A1, Hybridoma
Bank) 1:50; rabbit anti-GFP (AbCAM #290) 1:2000; mouse anti-Dlg (4F3,
Hybridoma Bank) 1:250; mouse anti--Spectrin (3A9, Hybridoma Bank),
1:10; mouse anti-GEF64C (Bashaw et al., 2001) 1:50; rabbit anti-
DRhoGEF2 (Padash Barmchi et al., 2005) 1:1000; rabbit anti-Myosin II
heavy chain (Bloor and Kiehart, 2001) 1:500; mouse anti-Rho1 (P1D9)
(Magie et al., 2002) 1:50 and Phalloidin Alexa-594 (Molecular Probes)
1:200. All dilutions were done in PBT (BSA 1% and Triton X-100 0.1% in
PBS). Secondary antibodies were coupled to Alexa488 or Alexa594
(Molecular Probes), and diluted in PBT at 1:400. Cuticle preparations were
done as described (Hu and Castelli-Gair, 1999).
RESULTS
Spiracle cell invagination involves apical
constriction and basolateral membrane
elongation
The posterior spiracles are the respiratory organ of the first instar
Drosophila larva. They contain an internal multicellular tube, the
spiracular chamber, which links the trachea to the exterior, allowing
gas exchange. Formation of the spiracular chamber begins at stage
11 (7 hours after egg laying), when a group of ~70 epithelial cells
localised posteriorly to the eighth abdominal tracheal pit start to
invaginate into the embryo (Hu and Castelli-Gair, 1999). We studied
spiracle cell behaviour during the invagination process by
performing time-lapse analysis in live Drosophila embryos
expressing DE-Cadherin fused to GFP (Oda and Tsukita, 2001). At
stage 11, when the embryonic germ band is fully extended, the
future spiracular chamber cells were still localised superficially and
were indistinguishable from the neighbouring cells (Fig. 1A, t=0
minutes, see Movie S1 in the supplementary material and Fig. 1B,
part i). As the germ band started to retract, the most anterior cells
rearranged their relative positions around the tracheal opening (Fig.
1B, part ii, arrow) until they met, forming a lumen in continuity with
the tracheal dorsal branch (Fig. 1B, part iii). During this
rearrangement, all the cells in the spiracle primordium constricted
apically, resulting in an inward depression of the tissue around the
luminal opening (Fig. 1A, t=134 minutes). This invagination
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occurred in a spatially and temporally controlled manner, as the cells
adjacent to the tracheal opening invaginated first (forming a lumen),
followed in turn by the more distal (posterior) cells (Fig. 1B, parts
iii,iv; see also the diagram in Fig. 1E). Apical constriction and
ordered invagination continued until the end of germ band retraction,
by which time all the spiracle chamber cells had invaginated into the
embryo, forming a tube continuous with the trachea (Fig. 1A, t=232
minutes, Fig. 1B, part v, and Fig. 1D).
To visualise the Actin cytoskeleton during the invagination
process, we expressed GFP-Actin in the spiracle invaginating cells
and followed in vivo cell shape changes. GFP-Actin preferentially
accumulated at the apical side of the invaginating cells, correlating
with constriction at that side (Fig. 1C). In a fully developed spiracle,
the luminal surface of the spiracular chamber was formed by the
apical side of the invaginated cells, and was also lined by F-Actin,
as revealed by Phalloidin staining (Fig. 1D). Simultaneously with
apical constriction, the invaginating cells elongated up to fourfold
at the opposite, basolateral, side, with the nucleus remaining basally
localised. After stage 16, spiracle cells secrete a refractive cuticle,
known as the Filzkörper, inside the luminal space, which works as
a filter during larval breathing (Hu and Castelli-Gair, 1999) (Fig.
3A).
Myosin II is apically enriched and essential for
spiracle invagination
Apical constriction and invagination of epithelial cells are generally
linked to recruitment of both F-Actin and Myosin II to the apical side
(Young et al., 1991). Using transgenic embryos expressing the
regulatory light chain of Myosin II [MRLC, encoded by the
spaghetti squash (sqh) gene] fused to GFP (Royou et al., 2002), or
antibodies against the heavy chain of Myosin II (Zip), we confirmed
that this Myosin was apically enriched in the cells forming the
spiracular chamber (see Fig. S1A in the supplementary material,
wild type). Furthermore, this enrichment correlated with the onset
of apical constriction. At stage 11, before cell invagination started,
Myosin II was distributed along the entire lateral membrane, co-
localising with the basolateral marker Dlg (Discs large) (Fig. 2A,
stage 11). As the spiracle cells began constricting apically, puncta of
Myosin II appeared on their apical side (Fig. 2A, stage 12). At stage
13, when the entire primordium had invaginated, Myosin II was
highly enriched apically, in a largely non-overlapping domain
relative to Dlg (Fig. 2A, stage 13). This localisation, together with
the observation that Actin also accumulates apically, co-localising
with Myosin II, suggests that a contractile force based on Actin and
Myosin II is acting during the process of invagination.
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Fig. 1. Posterior spiracle cell
invagination involves apical
constriction and basolateral
membrane elongation. (A) Stills of a
movie showing the A8 segment
(bracket) of a DE-Cad-GFP-expressing
embryo. At stage 11 (t=0 minutes),
spiracular chamber cells (dashed line)
are superﬁcial and localise posteriorly to
the A8 tracheal pit (arrow). Later, notice
apical constriction and inward cell
movement to form a lumen (arrow).
(B) Spiracle cells are expressing -
Catenin-GFP (green), using the ems-
GAL4 driver (spiracle-speciﬁc); Armadillo
(-Catenin) is in red. All images are top
views. (i,ii) Initial lumen formation (stage
11) involves rearrangement of the most
anterior cells (arrowheads) around the
tracheal opening (arrow). (iii) the more
posterior cells (left from white outline)
constrict apically and invaginate later
(iv), to form the complete chamber (v).
(C) Stills of a live embryo expressing
GFP-Actin in the spiracle invaginating
cells. t=0 minutes corresponds to end of
stage 12. Notice apical enrichment of
GFP-Actin and elongation of the
basolateral cell domain, with the cell
nuclei (black) remaining basally
localised. (D) Phalloidin staining (red) in
the spiracular chamber cells expressing
GFP (green). Notice the accumulation of
F-Actin at the apical/luminal side of the
spiracular chamber cells (lateral view).
(E) Diagram showing invagination of the posterior spiracle cells (lateral view). The cells belonging to the spiracle primordium (red and green)
constrict apically (i,ii); the more anterior cells (red) rearrange around the A8 tracheal dorsal branch (DB) (iii) and invaginate ﬁrst, occupying deeper
positions in the spiracle. These are followed by the most posterior cells (green), which then occupy more superﬁcial positions. The invaginated
cells form a multicellular tube (spiracular chamber) in continuity with the tracheal dorsal trunk. During invagination, cells also elongate their
basolateral membrane, acquiring a bottle shape (iv). Anterior is to the left in all panels; note that in the extended germ band stage (stage 11) the
anterior cells are on the right side because the embryo is folded. Scale bars: 20 m in A; 10 m in B-D. DT, tracheal dorsal trunk; SC, spiracular
chamber.
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To test this hypothesis, we analysed the morphology of the
spiracular chamber in embryos with a strong reduction in the
maternal and zygotic levels of MRLC, by making germline clones
of a hypomorphic mutation in sqh, sqh1 (Karess et al., 1991). This
mutation, as opposed to null mutations in Myosin II, does not
abolish egg laying (Barros et al., 2003) and allows embryonic
development to proceed beyond spiracle formation. Consistent
with a role for apical Myosin II in exerting the driving force
during cell invagination, spiracle cells failed to invaginate and to
form a lumen in sqh1GLC embryos (Fig. 2B, part i). In addition,
clusters of cells were seen detached from the main group (Fig. 2B,
part i, arrowhead), suggesting that Myosin II is also important in
coordinating cellular movement during invagination. Although
Actin was still apically enriched in most of the spiracle cells in
these mutants, failure in apical constriction was occasionally
observed (Fig. 2Bi). Embryos that were rescued by the paternal
contribution of MRLC exhibited a milder phenotype, in which
spiracle cells were able to invaginate but failed to form a lumen,
showing a disrupted apical Actin cytoskeleton (Fig. 2B, part ii,
arrow; compare with wild type in Fig. 2B). These observations
demonstrate that apical Myosin II, together with Actin, is
essential to correctly drive epithelial cell invagination and lumen
formation.
Rho1 is essential for epithelial cell invagination
The small GTPase Rho is known to promote Myosin II activity via
Rho-Kinase (ROCK) activation, and to stimulate Actin
polymerisation via Formin activation (Narumiya et al., 1997). Thus,
apical enrichment of F-Actin and Myosin II during spiracle cell
invagination suggests the involvement of Drosophila Rho1 in this
process. To test this hypothesis, we analysed spiracle morphology in
both zygotic and maternal/zygotic mutants for Rho1, using the wimp
strategy (Magie et al., 1999). In both cases, a large majority of
Rho11B null embryos showed a dilated or irregular Filzkörper,
especially at the most distal part of the tube, symptomatic of
disrupted invagination (75.8% in zygotic Rho11B mutants, n=116
and 69% in Rho11B maternal/zygotic mutants, n=185) (Fig. 3B;
compare with wild type, Fig. 3A). These defects correlated with a
partial disruption of the cortical Actin cytoskeleton in the spiracular
chamber of late embryos (Fig. 3D). Additionally, in these
experiments about 4% of zygotic Rho11B mutants and 13% of
maternal/zygotic mutants showed a complete failure in spiracle cell
invagination (Fig. 3C), with the Filzkörper forming on the surface
of the embryo. These observations suggest that Rho1 activity is
essential for proper epithelial cell invagination and tubulogenesis
and controls the assembly of apical Actin during this process.
Similar results were obtained by spiracle-specific expression of a
dominant negative Rho protein (RhoN19), which led to a block of
the invagination process, causing the spiracle cells to remain on the
surface of the embryo (Fig. 3E,F). These uninvaginated cells showed
a disrupted cortical Actin cytoskeleton at their apical side,
correlating with a non-uniform pattern of apical Myosin II (Fig. 3H,
arrowhead; compare with wild type, Fig. 3G, and see Fig. S1A in the
supplementary material). Nevertheless, as observed in Rho1
mutants, elongation of the basolateral membrane could still be
observed, indicating that Rho1 function is not required for this
process (Fig. 3H, arrow). Knocking down Rho1 activity also
affected the establishment of proper apical cell-cell adhesion, as
assessed by the defects seen in the adherens junctions architecture
(see Fig. S1B in the supplementary material).
Rho1 activity is apically restricted during spiracle
cell invagination
Loss of Rho1 function led to apical but not basolateral defects in the
invaginating spiracle cells, suggesting that the activity of this
GTPase is required apically during such morphogenetic movement.
This prediction is further supported by two lines of evidence. First,
immunofluorescence against Rho1 protein revealed that, despite
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Fig. 2. Myosin II is apically enriched and essential for spiracle invagination. (A) Myosin II distribution is visualised in the spiracular chamber
cells using embryos expressing Myosin II regulatory light chain (Spaghetti squash) fused to GFP (Sqh-GFP). Discs large (Dlg) (red) labels the
basolateral membrane at stage 11/12 and only the lateral membrane at stage 13. The images are sagittal views and brackets indicate the position
of the invaginating spiracle cells. Apical is up. (B) Spiracular chamber defects in sqh1GLC embryos (i,ii) compared with wild type; spiracular chamber
cells are labelled with GFP-Actin, using the ems-GAL4 driver. In i, spiracle cells remain on the surface of the embryo; the arrowhead indicates two
spiracle cells detached from the main cluster; notice that some cells fail apical constriction (cell labelled with bracket in i, which is a magniﬁcation
of the rectangle in i), as opposed to other cells with a wedge shape and high accumulation of apical Actin (e.g. cell labelled with an asterisk).
(ii) The arrow indicates the disrupted pattern of apical Actin in the mild class of sqh1GLC spiracles. Scale bars: 10 m.
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being ubiquitous, Rho1 was strongly enriched on the apical side of
the invaginating spiracle cells, surrounding the lumen of the
spiracular chamber (Fig. 4A, parts i,ii). Second, we developed a
GFP-based probe (herein termed PKNG58AeGFP), which
recognizes the active, GTP-bound form of Rho1 and that can be
expressed in vivo using the UAS/GAL4 system (see Fig. S2 in
the supplementary material). To follow Rho1 activation and,
simultaneously, Actin distribution, during invagination and tube
formation, we expressed this probe together with mRFP-Actin in the
spiracle cells. At stage 11, before the onset of epithelial cell
invagination, PKNG58AeGFP appeared diffuse throughout the
spiracle primordium (Fig. 4B, early stage 11). Slightly later, a
distinct accumulation of the GFP signal was seen in the first
invaginating cells adjacent to the last tracheal pit, and this was
accompanied by a higher accumulation of mRFP-Actin in these cells
(Fig. 4B, late stage 11). During apical constriction and spiracle cell
elongation, our probe accumulated exclusively at the most apical
side of the invaginating cells, where mRFP-Actin was also found
(Fig. 4B, b.c.). After invagination, PKNG58AeGFP and mRFP-
Actin were still detected apically, surrounding the lumen of the
spiracular chamber (Fig. 4B, stage 13 and stage 17). Similar results
were observed using six independent transgenic lines of UAS-
PKNG58AeGFP, without any obvious phenotypic defects in spiracle
morphogenesis.
To study the functional relevance of restricting Rho1 activity to
the apical membrane during cell invagination, we analysed the
effects of activating this GTPase in a spatially unrestricted manner,
by overexpressing the constitutively activated form of Rho1,
RhoV14, using the spiracle driver ems-GAL4. Simultaneous
expression of our PKNG58AeGFP probe confirmed that Rho1
activity was ectopically detected throughout the entire plasma
membrane upon expression of this activated form of Rho1 (Fig. 4C,
part i; compare with wild-type control, Fig. 4C, left panel).
Unrestricted Rho1 activation led to obvious defects in spiracle cell
shape and localisation in late embryos: clusters of mini-bottle-
shaped cells were seen superficially localised, indicating that ectopic
Rho1 activation blocks spiracle cell invagination and inhibits the
elongation of their basolateral membranes (Fig. 4C, part ii; compare
with wild-type control in Fig. 3G). These RhoV14-expressing cells
could still apically constrict and accumulate higher amounts of GFP-
Actin on their apical side, probably due to the additive effect of the
endogenous Rho1. Nevertheless, they failed to form a lumen, as
assessed by the very disorganised and superficially localised
Filzkörpers (Fig. 4C, part iii). We conclude that wild-type spiracle
cell elongation and correct invagination/lumen formation require
Rho1 to be active exclusively on the apical membrane.
RhoGEF64C mRNA and protein are apically
localised in the spiracle cells
To further understand the mechanism by which Rho1 activity is
apically restricted, we searched for Rho activators that are expressed
during spiracle invagination. We found that RhoGEF64C, previously
described to regulate Rho1 in the embryonic central nervous system
(Bashaw et al., 2001), was specifically expressed by the invaginating
spiracle cells from early stage 12 until the spiracular chamber was
fully formed (Fig. 5A). This RhoGEF is also present in other
multicellular tubes, including the salivary glands, foregut and
hindgut and at low levels in the epidermis.
Immunostaining of RhoGEF64C with a specific monoclonal
antibody (Bashaw et al., 2001) showed that this RhoGEF localised
apically, overlapping with the polymerised F-Actin surrounding the
lumen of the spiracular chamber (Fig. 5B). Strikingly, we observed
that RhoGEF64C mRNA was also apically enriched in the
invaginating spiracle cells (Fig. 5C) and in the hindgut (Fig. 5D),
indicating that this mRNA can be apically transported in epithelial
cells. These observations suggest the possibility that RhoGEF64C
activity is spatially controlled by apical targeting of its mRNA,
followed by local translation.
To find the sequence elements responsible for the apical
localization of RhoGEF64C mRNA, we overexpressed several
truncations of RhoGEF64C cDNA in the posterior spiracles and
assessed for mRNA localisation. Neither truncating the 5UTR
alone (UAS-RhoGEF64C FL, full length) (Bashaw et al., 2001)
nor both the 5UTR and the 3UTR (UAS-RhoGEF64C
53UTR) affected the apical localisation of RhoGEF64C
mRNA. However, a deletion of 1.8 kb from the 3 region, including
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Fig. 3. Rho1 is essential for spiracle invagination. (A) Wild-type Filzkörpers. (B) Cuticle of a null mutant for Rho1 (Rho11B) showing irregular
Filzkörpers (arrows). (C) Severe class of Rho11B embryos, with one uninvaginated Filzkörper. (D) GFP-Actin (green) distribution in the spiracular
chamber of wild type and Rho11B/Rho172R mutants (stage 17); red, Filzkörper autoﬂuorescence obtained with the 488 nm laser. In wild-type
spiracles, a continuous line of Actin surrounds the Filzkörper, while in late Rho1 mutants this pattern is partially lost. (E,F) Expression of the
dominant negative form of Rho1, RhoN19, impairs Filzkörper secretion (E) and the invagination of spiracle cells (F, arrow); green, GFP-Actin.
(G,H) Wild-type spiracle and a spiracle in which RhoN19 has been expressed visualised with GFP-Actin. Expression of RhoN19 disrupts the
accumulation of apical Actin (arrowhead), while elongation of the basolateral membrane is still observed (arrow). Scale bars: 10 m.
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the 3UTR, the Dbl domain (Rho interacting domain) and
a putative PH domain (Pleckstrin Homology) (UAS-
RhoGEF64CDbl) (Bashaw et al., 2001), disrupted apical mRNA
localisation in the posterior spiracles (Fig. 5E). We conclude that
the apical localising element(s) of RhoGEF64C mRNA are
situated within the C-terminal coding region, which includes the
Dbl and PH domains of this RhoGEF.
RhoGEF64C and RhoGEF2 promote apical Rho1
activity during the formation of the spiracular
chamber
The apical localisation of RhoGEF64C makes it a good candidate
for regulating Rho1 in a polarised manner during invagination. To
test this, we co-expressed RhoGEF64C (UAS-RhoGEF64C FL) and
the dominant negative form of Rho1, RhoN19, in the spiracle cells.
RESEARCH ARTICLE Development 133 (21)
Fig. 4. Rho1 activity is apically restricted during spiracular chamber formation. (A) Immunoﬂuorescence against Rho1 protein showing its
apical accumulation around the lumen of the spiracular chamber (arrows); (i) dorsal view and (ii) lateral view. (ii) The PKNG58AeGFP probe overlaps
with apical Rho1, reﬂecting the local activation of this RhoGTPase. (B) Rho1 activity during formation of the spiracular chamber. Spiracle cells co-
expressing PKNG58AeGFP and mRFP-Actin. early st11 – low levels of PKNG58AeGFP are detected throughout the spiracle primodium. The asterisk
indicates the A8 tracheal pit position. Anterior is to the right; late st11 – the onset of Rho1 activity is detected in the ﬁrst invaginating cells (arrow)
localised posteriorly to the last tracheal pit. Notice also the higher accumulation of mRFP-Actin in these cells; b.c. – single invaginating bottle-
shaped cell showing apical activation of Rho1 (arrowhead), which overlaps with apical accumulation of mRFP-Actin (apical is up); stage 13 and
stage 17 – transverse and lateral views, respectively, of spiracular chambers showing accumulation of Rho1-GTP and mRFP-Actin at the
luminal/apical surface (arrows). (C) Ectopic Rho1 activation blocks basolateral elongation and impairs cell invagination. The left panel shows active
Rho1 (PKNG58AeGFP ﬂuorescence) around the lumen of a wild-type spiracle (lateral view, stage 14); the dashed line outlines a single invaginated
cell. The two middle panels represent spiracle cells co-expressing RhoV14 and PKNG58AeGFP (i) or GFP-Actin (ii). The right panel (iii) shows the
Filzkorper defects (arrows) caused by the expression of RhoV14 (cuticle). In i, ectopic Rho1 activation is detectable on the cell membranes, as
opposed to the apically restricted pattern in the wild type (same confocal settings as the WT control). ii shows a cluster of three spiracle cells with a
mini-bottle shape, due to inhibition of basolateral elongation (compare with wild-type control, Fig. 3G). Scale bars: 10 m, except B b.c, 3 m.
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This dominant negative mutant is expected to interfere with Rho1
function by sequestering its specific RhoGEFs. Accordingly, the
expression of the apical RhoGEF64C was able to rescue the
invagination defects caused by RhoN19, allowing the formation of
normal spiracular chambers (73.8%, n=157) (compare Fig. 5F with
Fig. 3E). By contrast, the truncated version, which lacked the Rho
interacting domain (Dbl domain) and failed to localize apically,
RhoGEF64CDbl, did not revert the RhoN19 phenotype. We
conclude that RhoGEF64C acts as a Rho1 activator during the
formation of the spiracular chamber.
To further investigate the function of RhoGEF64C in controlling
Rho1 activity, we eliminated RhoGEF64C function by RNAi,
injecting dsRNA for this RhoGEF into syncitial embryos carrying
the transgenes ems-GAL4 (spiracle-specific) and UAS-GFP-Actin.
Spiracle cells in RhoGEF64C RNAi embryos underwent normal
invagination and lumen formation; however, at stage 17, these
embryos showed an irregular Filzkörper, which correlated with a
mild disruption of the cortical Actin cytoskeleton lining the lumen
of the spiracular chamber (55%, n=126) (Fig. 5G). These defects are
compatible with a partial loss of Rho1 activity (compare with Rho1
zygotic mutants, Fig. 3D) and were similarly found in homozygous
embryos for the null alleles Rhogef64C1 and Rhogef64C29 (Bashaw
et al., 2001) (data not shown).
As the loss of function of RhoGEF64C did not cause invagination
defects, as observed after the complete loss of Rho1 activity, we
predicted that other RhoGEF(s) could be acting together with
RhoGEF64C to activate Rho1 apically. A probable candidate is the
ubiquitous and apically localised RhoGEF2, which is Rho1-specific
and regulates epithelial cell invagination during development
(Nikolaidou and Barrett, 2004; Padash Barmchi et al., 2005). We
confirmed the expression and found an apical enrichment of
DRhoGEF2 before and during invagination of the spiracle cells,
overlapping with apical Actin (Fig. 6B and see Fig. S3 in the
supplementary material). Furthermore, 34% of maternal and zygotic
mutants for the null allele DRhoGEF2l(2)04291 (DRhoGEF2 MZ)
(Hacker and Perrimon, 1998) failed spiracle invagination, 26%
presented lumen defects and 3.5% showed both defects (n=201) (see
Fig. S3 in the supplementary material). DRhoGEF2 MZ embryos
that were also heterozygous or homozygous (1:1) for the
Rhogef64C1 null allele showed a mild increase in the frequency of
spiracle defects (invagination defects, 31%; lumen defects, 35%;
both defects, 8%; n=86). Taken together, these results show that at
least two apical RhoGEFs, RhoGEF2 and RhoGEF64C, contribute
to activate Rho1 apically during spiracle cell invagination.
RhoGAP Cv-c is localised basolaterally and is
required for proper apical Rho1 activity
One emerging theme in small Rho GTPase regulation studies is that
cycling between their GTP- and GDP-bound states might be
required for effective signal flow in order to elicit downstream
biological functions (Moon and Zheng, 2003). RhoGAPs are
important players in this balance, as they accelerate the return of
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Fig. 5. RhoGEF64C is a positive
regulator of Rho1 and its mRNA and
protein are apically localised. (A) In
situ hybridisation for RhoGEF64C
showing expression in the posterior
spiracle primordium (black arrows) and
hindgut (white arrowhead), during
retraction of the germ band.
(B) Staining for the apical RhoGEF64C
(red) in GFP-Actin expressing spiracle
cells (stage 15). (C,D) RhoGEF64C
mRNA is apically localised, surrounding
the lumen of the posterior spiracles (C,
lateral view) and hindgut (D, dorsal
view) (stage 15). (E) Deletion of the Dbl
plus PH domain (GEF64CDbl)
abrogates apical localisation of
RhoGEF64C mRNA in the posterior
spiracles, as opposed to truncations of
the UTR regions (GEF64C FL (5UTR)
and GEF64C 53UTR); CDS – coding
sequence. Dorsal views. (F) Expression
of RhoGEF64C FL rescues the RhoN19-
induced phenotype, as opposed to the
truncated form RhoGEF64CDbl.
(G) RhoGEF64C RNAi downregulates
the expression of this gene, as assessed
by in situ hybridisation. Notice the
formation of irregular Filzkörpers with
partially disrupted cortical Actin. Green,
GFP-Actin. Scale bars: 50 m in A; 10
m in B-D,F,G; and 20 m in E.
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RhoGTPases to their inactive state, and thus may act as positive
regulators of Rho function (Symons and Settleman, 2000).
Consistent with this view, previous work has implicated the
RhoGAP Cv-c in spiracle cell invagination (Denholm et al., 2005).
Zygotic cv-c mutants (cv-c7) showed partial or complete
invagination defects in their posterior spiracles, with a strongly
disorganised pattern of apical Actin (Fig. 6A). As the vertebrate
homologues of cv-c, p122/DLC-1 and DLC-2, were shown to act on
RhoA, the mammalian homologue of Drosophila Rho1 (Leung et
al., 2005; Wong et al., 2003), we hypothesised that Cv-c could also
regulate Rho1 cycling during spiracle morphogenesis.
To determine the intracellular localisation of Cv-c, and compare
it with the above-described RhoGEFs, we fused Cv-c to the modified
YFP, Venus, and expressed this fusion in the spiracular chamber
cells. Interestingly, and opposed to the exclusive apical localisation
of the two RhoGEFs described above, RhoGAP Cv-c mainly
localised to the basolateral membrane, overlapping with the
basolateral marker -Spectrin (Fig. 6Bi-iii). Double labelling of
RhoGEF2 and Cv-c confirmed that these two classes of Rho
regulators essentially occupied non-overlapping domains in the
membrane of the invaginating cells, the apical and basolateral
domains, respectively (Fig. 6Bi-iii).
To test whether Cv-c controls Rho1 activity during cell
invagination, we overexpressed this RhoGAP in the spiracle cells. An
increased expression of a RhoGAP is expected to downregulate the
activity of the target RhoGTPase(s), thus mimicking the phenotype
produced by the expression of their dominant negative forms. Gain
of function of Cv-c [using UAS-Cv-c (Denholm et al., 2005)] caused
RESEARCH ARTICLE Development 133 (21)
Fig. 6. RhoGAP Cv-c is localised basolaterally and controls Rho1 activity. (A) Cuticles and distribution of GFP-Actin (green) in the spiracles of
wild-type and cv-c7 mutant embryos. Notice the partially uninvaginated Filzkörpers in cv-c7 mutants (arrows) accompanied by disruption of the
apical Actin (inset). (B) Expression of Venus-Cv-c (green) in spiracle cells using the ems-GAL4 driver, co-stained with the basolateral marker -
Spectrin (red) (i-iii) and with RhoGEF2 (red) (i-iii). (C) Cv-c gain of function (using emsGAL4 and UAS-Cv-c) leads to invagination failure of the most
distal cells of the spiracular chamber (arrowheads) correlating with a disruption of their apical Actin (arrow). Green, GFP-Actin; red, Armadillo.
(D) PKNG58AeGFP (i) and mRFP-Actin (i) proﬁles in spiracles overexpressing RhoGAP Cv-c. The cell cluster on the right (bracket) failed invagination
and shows weaker apical Rho1 activity (yellow arrowhead) than the remaining invaginated cells (white arrowhead). (E) PKNG58AeGFP expression in
a cv-c7 mutant spiracle with a severe phenotype. Apical and basal sections (dorsal view) and probe distribution along the xz axis. Notice the apical
restriction of active Rho1, non-uniformly associated with the apical junctions. Scale bars: 10 m.
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phenotypic defects similar to Rho1 loss of function (Rho1 mutants
and UAS-RhoN19), but not to Rac loss of function (UAS-RacN17,
see also Fig. S1B in the supplementary material): irregular
Filzkörpers at the distal end and partially uninvaginated spiracles
(compare Fig. 6C with wild type in Fig. S1B in the supplementary
material). Frequently, the distal cells of the spiracular chamber failed
to invaginate and showed decreased Rho1 activity, as confirmed by
the lower levels of apical PKNG58AeGFP fluorescence (Fig. 6D).
Furthermore, these cells maintained an elongated shape, but their
apical Actin cytoskeleton was highly disrupted (Fig. 6C), in a manner
similar to that observed upon expression of RhoN19 (Fig. 3H).
Expression of stronger transgenic lines of UAS-Venus-Cv-c led to
completely uninvaginated spiracles and fully phenocopied the defects
caused by RhoN19 (data not shown). Together, these results indicate
that Cv-c acts as a Rho1-GAP, being mainly excluded from the apical
membrane domain in which Rho1 is active.
To test whether Cv-c is excluding Rho1 activity from the
basolateral membrane, we expressed the PKNG58AeGFP probe in
the spiracles of cv-c7 mutants. In these embryos we did not observe
an increase in PKNG58AeGFP fluorescence on the basolateral
membrane (Fig. 6E, xz axis projection), nor defects on spiracle cell
elongation (which would be indicative of basolateral Rho1
activation, as shown in Fig. 4C). This suggests that other factors in
addition to Cv-c act to exclude active Rho1 from this membrane
domain. However, cv-c7 mutants show a pattern of active Rho1
restricted to the apical junctions in a non-uniform manner and not
covering the entire apical membrane (Fig. 6E), as opposed to the
wild type, where active Rho1 is found uniformly associated with the
apical membrane (Fig. 4B, stage 17). These observations suggest
that the absence of this RhoGAP leads to lower levels of apical
Rho1-GTP, which correlate with the defects seen in the apical Actin
cytoskeleton.
DISCUSSION
In this work we address the contribution of Rho1 activity and its
spatial control during morphogenesis, using the posterior spiracles
of the Drosophila embryo as a model. The formation of this organ
involves dramatic changes in epithelial cell shape, which are very
common during cell invagination, namely constriction at the apical
side and elongation of the basolateral cell domain. These two
contrasting behaviours at opposite cell poles induce tissue
invagination.
Using a probe that allows the visualisation of Rho1 activity in the
course of normal development, we present evidence that this GTPase
is active at the apical side during the process of cell invagination. In
the spiracles Rho1 activity is essential to control this movement,
similarly to that previously shown during Drosophila gastrulation,
when mesodermal cells fail to invaginate after inhibition of Rho1
function (Barrett et al., 1997; Hacker and Perrimon, 1998). We also
observed an apical enrichment of Myosin II, a possible target of
activated Rho1, analogous to that reported in other tissues of the fly
embryo where this type of movement occurs, such as the mesoderm
and the salivary glands (Nikolaidou and Barrett, 2004). Inhibition of
Rho1 activity results in a disorganised pattern of apical Myosin II
and F-Actin in the spiracle cells. We suggest that concentration of
active Rho1 at the apical side organises the Actin cytoskeleton and
promotes high Myosin II accumulation/activity in this region,
leading to a contractile Actin-Myosin based force to produce a
wedge-shaped cell.
Our data show that spatial restriction of Rho1 activity is achieved
by distinct mechanisms. First, albeit ubiquitous, Rho1 protein is
strongly enriched on the apical side of the invaginating spiracle cells.
Second, to ensure that this GTPase is active exclusively on that side
of the cell, opposing Rho regulators are differentially distributed in
two distinct membrane domains: two Rho activators, RhoGEF64C
and RhoGEF2, are apically localised, whereas a Rho inhibitor, the
RhoGAP Cv-c, occupies the complementary, basolateral domain.
As we have shown, cell shape changes and inward cell movements
driving invagination are impaired if Rho1 becomes activated in a
spatially unrestricted manner. These observations stress the
importance of finely tuning Rho1 localisation and activation during
normal tissue morphogenesis.
Several mechanisms might be at work to achieve the specific
localisation of the Rho regulators that direct cell invagination. In the
case of RhoGEF64C we show that its mRNA and protein are
apically localised, suggesting that apical transport of RhoGEF
mRNA followed by local translation is a mechanism to activate
Rho1 in a spatially restricted manner. Recent studies show that the
mRNA of RhoA can also be transported and locally translated in the
axons and growth cones of embryonic rat neurons, where RhoA
controls growth cone collapse in response to Semaphorin 3A (Wu et
al., 2005). This shows that intracellular mRNA transport of Rho
GTPases and of their regulators may be an important mechanism to
control spatial GTPase activation.
Loss of function of the RhoGEFs involved in spiracle invagination
leads to variable apical defects, which are compatible with a partial
loss of Rho1 function: knocking out RhoGEF64C resulted in a mild
disruption of cortical Actin without blocking invagination, while the
absence of RhoGEF2 could result in a complete failure of the
invagination process. These results suggest that several RhoGEFs
are required to properly activate Rho1 during spiracle cell movement
and organ shaping.
One interesting observation from our studies is the fact that
mutants for the RhoGAP Cv-c did not show ectopic activated Rho1
on the basolateral membrane where this RhoGAP was localised.
Thus, several mechanisms must be at work to ensure that Rho1
activity is excluded from the basolateral domain during cell
invagination: the presence of at least one RhoGAP on the basal
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Fig. 7. Model for Rho1 activity during spiracle cell invagination
and tube formation. Rho1 is exclusively active at the apical domain of
the invaginating cells that form the spiracular chamber, by the action of
RhoGEF2 and RhoGEF64C. At the apical side Rho1-GTP promotes
Myosin II and F-Actin assembly/activity, being essential for correct cell
invagination and lumen maintenance. Rho1 function is excluded from
the basolateral domain both by the absence of RhoGEF activity and by
the presence of the RhoGAP Cv-c. Inactivation of Rho1 at the
basolateral domain is also required to maintain the steady state levels of
apical Rho1-GTP.
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membrane, the apical restriction of RhoGEFs and the existence of
low levels of Rho1 protein on the basolateral side of the cells. In
addition, we also observed that spiracles from severe cv-c mutants
showed lower levels of apical Rho1-GTP than their wild-type
counterparts, correlating with the disruption of their apical Actin.
Defects in apical Actin/Myosin II were also reported during
invagination of the tracheal pits in cv-c mutants (Brodu and
Casanova, 2006). Taken together, these observations suggest that
GTP hydrolysis is a necessary step in the regulation of Rho1
function during cell invagination and the RhoGAP Cv-c may help to
maintain a steady state level of apical Rho1-GTP.
Based on the differential distribution of Rho1 GEFs and GAPs,
we propose a model in which Rho1 must shuttle back and forth
between two membrane compartments, being GTP-bound on the
apical cell membrane and GDP-bound on the basolateral side (Fig.
7). Thus, during tissue morphogenesis, epithelial cells can couple
their apical-basal polarity to the spatial control of small RhoGTPase
function.
RhoGTPases act as dynamic switches in many developmental and
cellular contexts. In order to understand how they orchestrate these
dynamic processes, their activity states needs to be visualised over
time. We anticipate that this work and the tools described will
provide a basis for studying Rho1 activity in vivo. It will be
interesting to extend this analysis to other contexts in which Rho
GTPases are known to act – such a dorsal closure, neurulation,
wound healing – and to identify the Rho regulators involved in each
case, relating their spatial/temporal distribution with the patterns of
Rho GTPase activity.
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